Pyxis (PYXS) Sof foyda bo'yicha sotuv rentabelligi

Pyxis Oncology Inc. (PYXS) tovar belgisi

Pyxis Oncology, Inc. (PYXS) o'zining immuno-onkologiya patent portfeli asosida spekulyativ biznes ustunligini saqlab qolmoqda. Rahbariyatning yuqori ilmiy ekspertizasi ADC dori vositalarini ishlab chiqishda shaffoflikni ta'minlaydi. Kompaniyaning sof marja koeffitsiyenti foiz stavkalariga moslashuvchanlikni namoyish etadi, -785.50 esa ushbu ko'rsatkichning so'nggi qiymatini aks ettiradi. Innovatsion davolash usullari va shaxsiy antitanachlar kelgusidagi sotuvlar orqali monetizatsiya qilinadigan kapitalni shakllantiradi.

PYXS: pyxisoncology.com Kompaniyaning sof rentabelligi 04.07.2022 - 20.11.2026

Pyxis Oncology, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Pyxis - PYXS
pyxisoncology.com yetakchi tovari

Ushbu ko'rsatkich sof foydaning umumiy daromadga nisbati sifatida hisoblanadi va barcha operatsion hamda soliq xarajatlari chegirib tashlanganidan keyin biznesda qolgan kapital qismini belgilaydi. Pyxis Oncology, Inc. (PYXS) uchun sof foyda marjasining salbiy qiymatlari klinik sinovlar va R&D ga yo'naltirilgan ulkan xarajatlar bilan bog'liq bo'lib, bu yuqori texnologiyali saraton immunoterapiyasi sektori uchun odatiy holdir.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)